Ocular Therapeutix's (OCUL) probability of success for its Axpaxli drug in wet age-related macular degeneration, or wAMD, is still 75%, UBS analysts said in a Monday note. The not ...
Jefferies, the investment bank, estimates a 59% probability that AstraZeneca PLC (LSE:AZN, NYSE:AZN)’s zibotentan succeeds in ...
Recent share price weakness is due to temporary headwinds, including client cost-cutting and delays in biotech decision-making, not structural issues in the CRO industry. Long-term prospects remain ...
SELLAS Life Sciences is rated Hold, with a $9.25 price target, as the current valuation reflects REGAL trial success probability. Read more on SLS stock here.
As AI becomes more accessible, higher education is increasingly turning to prediction algorithms to inform decisions and target support services. Prediction algorithms can underestimate success for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results